This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0021246305 Reproduction Date:
InChI=1S/C19H22BrNO3/c1-22-16-7-5-4-6-12(16)10-21-11-13-8-14-18(13)17(23-2)9-15(20)19(14)24-3/h4-7,9,13,21H,8,10-11H2,1-3H3/t13-/m0/s1 Y Key:CLSBQRBXTFTLEX-ZDUSSCGKSA-N Y
2CBCB-NBOMe (NBOMe-TCB-2) is a compound indirectly derived from the phenethylamine series of hallucinogens, which was discovered in 2007 at Purdue University as part of the ongoing research program of the team led by David Nichols focusing on the mapping of the specific amino acid residues responsible for ligand binding to the 5HT2A receptor. 2CBCB-NBOMe acts as a potent and selective agonist for the 5-HT2A and 5-HT2C receptors, with a Ki of 0.27nM at the human 5-HT2A receptor, a similar potency to other agonists such as TCB-2, NBOMe-2C-I and Bromo-DragonFLY.[1]
Amphetamine, Cocaine, Iron, Zinc, Methamphetamine
5-Methoxytryptamine, Metitepine, Lysergic acid diethylamide, Bromocriptine, Methysergide
5-Carboxamidotryptamine, Metitepine, Lysergic acid diethylamide, Bromocriptine, Methysergide
Dark matter, Rice University, Italy, Columbia University, Gran Sasso National Laboratory
Lysergic acid diethylamide, 5-Carboxamidotryptamine, 5-Methoxytryptamine, Metitepine, Xenon
Ergoline, Serotonin, Lysergic acid diethylamide, 5-Methoxytryptamine, Methysergide
Ergoline, Serotonin, Lysergic acid diethylamide, Substituted tryptamine, 5-Methoxytryptamine
Ergoline, Serotonin, Lysergic acid diethylamide, Amphetamine, 5-Methoxytryptamine